Home | Welcome to Contract Pharma   
Last Updated Monday, December 22 2014

Print

Financial Report: Sanofi



Published August 8, 2014
Sanofi

2Q Revenues: €8.1 billion (+1%)

2Q Earnings: €1.5 billion (+4%)

YTD Revenues: €15.9 billion (-1%)

YTD Earnings: €3.1 billion (flat)

Comments: Pharmaceutical sales were up 7% to €6.8 billion. Diabetes division sales were up 16% to €1.8 billion in the quarter driven by Lantus (up 16% to €1.6 billion). Genzyme sales were up 29% to €643 million, driven by the growth of Aubagio and Fabrazyme. Sanofi Pasteur sales were flat at €718 million reflecting continued gradual recovery of Pentacel, strong performance of Flu vaccines, which was offset by lower Booster vaccines sales. Consumer Healthcare sales were €816 million, up 20%.


blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On